The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(3-(Cyclohexyloxy)benzyl)piperidin-4-yl)-5-methylpyrimidine-2,4(1H,3H)-dione ID: ALA4864545
PubChem CID: 164624036
Max Phase: Preclinical
Molecular Formula: C23H31N3O3
Molecular Weight: 397.52
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cn(C2CCN(Cc3cccc(OC4CCCCC4)c3)CC2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C23H31N3O3/c1-17-15-26(23(28)24-22(17)27)19-10-12-25(13-11-19)16-18-6-5-9-21(14-18)29-20-7-3-2-4-8-20/h5-6,9,14-15,19-20H,2-4,7-8,10-13,16H2,1H3,(H,24,27,28)
Standard InChI Key: LLKZVVMUQSSKDF-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
13.7019 -19.7795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4103 -20.1870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1173 -19.7773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8259 -20.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5325 -19.7782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5317 -18.9602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8183 -18.5529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1147 -18.9642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2406 -20.1861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9479 -19.7767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6553 -20.1898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3605 -19.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3638 -18.9664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6558 -18.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9445 -18.9639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0726 -18.5597 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7784 -18.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4851 -18.5712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4915 -17.7537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7851 -17.3410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0722 -17.7459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1901 -18.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2019 -17.3497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3659 -17.3349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7066 -18.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0023 -18.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2928 -18.9622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2921 -19.7804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0009 -20.1923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
5 9 1 0
9 10 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
13 16 1 0
16 17 1 0
16 21 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 1 0
18 22 1 0
19 23 2 0
21 24 2 0
1 25 1 0
1 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.52Molecular Weight (Monoisotopic): 397.2365AlogP: 3.39#Rotatable Bonds: 5Polar Surface Area: 67.33Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.32CX Basic pKa: 8.11CX LogP: 3.16CX LogD: 2.37Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.84Np Likeness Score: -0.73
References 1. Song L, Merceron R, Hulpia F, Lucía A, Gracia B, Jian Y, Risseeuw MDP, Verstraelen T, Cos P, Aínsa JA, Boshoff HI, Munier-Lehmann H, Savvides SN, Van Calenbergh S.. (2021) Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors., 225 [PMID:34450493 ] [10.1016/j.ejmech.2021.113784 ]